Redirection of the reaction between activated protein C and a serpin to the substrate pathway

Andrey A Komissarov1, Peter A Andreasen, Paul J Declerck

  • 1Department of Chemistry, Portland State University, P. O. Box 751, Portland, OR 97207-0751, USA. akomiss@pdx.edu

Thrombosis Research
|November 30, 2007
PubMed

Insights

Targeting plasminogen activator inhibitor 1 (PAI-1) with specific antibodies can protect activated protein C (APC) from inactivation. This strategy enhances APC’s therapeutic potential in severe sepsis by neutralizing PAI-1.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Immunology

Background:

  • Activated protein C (APC) is a crucial therapeutic agent for severe sepsis, but its efficacy is limited by inactivation from serine protease inhibitors (serpins).
  • Elevated levels of plasminogen activator inhibitor 1 (PAI-1), a specific serpin, are linked to poor outcomes in sepsis and disseminated intravascular coagulation.
  • Developing methods to protect APC from PAI-1 inactivation is essential for improving sepsis treatment.

Purpose of the Study:

  • To investigate intermolecular mechanisms for redirecting the reaction between PAI-1 and APC.
  • To explore the potential of neutralizing PAI-1 to enhance APC's therapeutic efficiency.

Main Methods:

  • Utilized SDS PAGE and fluorescence spectroscopy to analyze the reaction kinetics and stoichiometry.
  • Studied the effects of anti-PAI-1 monoclonal antibodies (mAbs), vitronectin, and their fragments.

Main Results:

  • Monoclonal antibodies targeting the alpha-helix F region of PAI-1 redirected 70-80% of the APC-PAI-1 reaction to the substrate pathway.
  • Vitronectin and its SMB domain enhanced the effect of mAbs but did not alter reaction stoichiometry.
  • Vitronectin increased the APC-PAI-1 reaction rate, while mAbs and the SMB domain did not.

Conclusions:

  • Ligands that bind to PAI-1's alpha-helix F can protect APC from inhibition, suggesting a therapeutic strategy.
  • The universal nature of proteinase/serpin interactions allows for similar approaches to enhance the inactivation of other serpins, preserving APC activity.
  • Targeting APC inhibitors pharmacologically offers potential therapeutic benefits in sepsis and related conditions.
Abstract

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...